BIOA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead the BioAge Labs Class Action Lawsuit

Lawsuit Overview - Purchasers or acquirers of BioAge Labs stock pursuant to its IPO have until March 10, 2025, to seek appointment as lead plaintiff in the class action lawsuit [1] - The lawsuit alleges violations of the Securities Act of 1933 by BioAge Labs and certain executives and directors [1] Case Allegations - BioAge Labs sold 12.65 million shares at $18.00 per share in its IPO [3] - The IPO offering documents allegedly contained materially false and/or misleading statements regarding safety concerns and expected results of the STRIDES clinical trial [4] - On December 6, 2024, BioAge Labs announced discontinuation of the STRIDES Phase 2 study due to liver transaminitis observed in some subjects receiving azelaprag [5] - Following this announcement, BioAge Labs stock price fell more than 76% and traded at or around $5.82 per share, significantly below the $18.00 IPO price [5] Lead Plaintiff Process - Any investor who purchased or acquired BioAge Labs stock pursuant to the IPO registration statement can seek appointment as lead plaintiff [6] - The lead plaintiff is typically the movant with the greatest financial interest in the relief sought and acts on behalf of all class members [6] - The lead plaintiff can select a law firm to litigate the case, and the ability to share in any potential future recovery is not dependent on serving as lead plaintiff [6] About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm representing investors in securities fraud cases [7] - The firm has secured the most monetary relief for investors in six out of the last ten years according to ISS Securities Class Action Services rankings [7] - Robbins Geller recovered $6.6 billion for investors in securities-related class action cases, over $2.2 billion more than any other law firm in the last four years [7] - The firm has 200 lawyers in 10 offices and has obtained many of the largest securities class action recoveries in history, including the largest ever at $7.2 billion in the Enron case [7]